UKAD 2018 Adam Fedorciow vs UKAD - Appeal

Related case:
UKAD 2017 UKAD vs Adam Fedorciow
February 8, 2018

On 8 February 2018 the National Anti-Doping Panel (NADP) decided to impose a 2 year period of ineligibility on the weight lifter Adam Fedorciow after his sample tested positive for the prohibited substance Higenamine.

Here the NADP considered that the Athlete gave a prompt admission, that the violation was not intentional and that there were no grounds to reduce the period of ineligibility from 2 years. The Panel ruled that he failed in his core responsibility to acquaint himself with the substances on the Prohibited List.

Hereafter in February 2018 the Athlete appealed the NADP decision with the Appeal Tribunal.

The Athlete requested the Appeal Tribunal to annul the NADP decision of 8 February 2018 on the basis that the NADP erred to properly apply the criteria and the definition for No Significant Fault or Negligence.

The Appeal Tribunal concludes that the NADP correctly considered and applied the definition of No Significant Fault or Negligence including the relevant jurisprudence. Also the NADP accurately did assess the evidence when rendering its decision that the Athlete failed to establish ‘No Significant Fault or Negligence’.

Therefore the Appeal Tribunal decides on 29 May 2018 to dismiss the Athlete’s appeal and to uphold the NADP decision of 8 February 2018.

Original document

Parameters

Legal Source
National Decisions
Date
29 May 2018
Arbitrator
Billington-Wood, Carole
Murdock, Colin
Summers, Jeremy
Original Source
UK Anti-Doping (UKAD)
Country
United Kingdom
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Case law / jurisprudence
Negligence
No intention to enhance performance
No Significant Fault or Negligence
Period of ineligibility
Prompt / Timely Admission
WADA Prohibited List International Standard
Sport/IFs
Weightlifting (IWF) - International Weightlifting Federation
Other organisations
British Weight Lifting Association (BWLA)
UK Anti-Doping (UKAD)
Laboratories
London, United Kingdom: Drug Control Centre
Doping classes
S3. Beta-2 Agonists
Substances
Higenamine
Various
Supplements
Document type
Pdf file
Date generated
4 June 2018
Date of last modification
14 June 2018
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin